We proved that the synergy of PRDX5 and Nrf2 could play an essential role in regulating the proliferation, drug resistance, and mechanism of NSCLC tumors in vivo and also consistent with LIOTTA’s research, ROS levels could lead to enhanced tumor cell metastasis [44]. This evidence concerns the gene PRDX5 and non-small cell lung carcinoma.